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Abstract
Photoreceptors undergo a constant renewal of their light sensitive outer segments 
(POSs). In the renewal process, 10% of the POS mass is daily phagocytized by the adja-
cent retinal pigment epithelium (RPE). POS contain vast amounts of 11-cis retinal and all-
trans-retinal, two highly reactive vitamin A aldehydes that spontaneously dimerize into 
lipid bisretinoids (LBs) and accumulate into RPE lysosomes during phagocytosis. As LBs 
are refractory to lysosomal hydrolases and RPE cells do not divide, this accumulation 
is irreversible and results in the formation of lipofuscin granules. Lipofuscin accumula-
tion is toxic for RPE cells through a variety of light-dependent and light-independent 
mechanisms. Beyond a threshold, RPE cells die resulting in secondary loss of overlying 
photoreceptors. Currently, there are no effective treatments for retinal disorders asso-
ciated with genetic or age-associated LB accumulation, such as Stargardt disease and 
age-related macular degeneration (AMD). Thus, there is a great need for medical inter-
ventions. Here, we discuss the current understanding of lipofuscin's pathogenicity and 
the status of different strategies under development to promote LB elimination from RPE 
lysosomes.
Keywords: lipofuscin, Stargardt, age-related macular degeneration (AMD), bisretinoids, 
retinal pigment epithelium (RPE), cyclodextrins, cellular clearance, TFEB, lysosome
1. Introduction
To understand the origin and consequences of the lysosomal accumulation of lipofuscin in the 
eye, a basic knowledge of retinal function and organization is required.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1.1. The retinal pigment epithelium (RPE) in vertebrate's eyes
Light entering the eye gets refracted by the cornea and lens on the neural retina, where photo-
receptors (PR) convert photons into a cascade of chemical and electrical events that propagate 
to second-order (horizontal, bipolar, and amacrine cells) and third-order (ganglion cells) reti-
nal neurons, which distribute this information to various visual centers of the brain through 
the fibers of the optic nerve. The bodies of PR cells, rods and cones, display three sectors 
(Figure 1): the outer segment, filled with stacks of disks densely packed with light-sensitive 
photopigment; the inner segment, filled with genetic, biosynthetic, and metabolic organelles 
Figure 1. Basic structure of retina's inverted architecture. Light travels through ganglion cells (GC) as well as second-
order neurons comprising bipolar (Bi), amacrine (A), horizontal (H), and Muller (M) cells, the retina. RPE localizes 
between the choroid capillaries and the cone (C) and rod (R) photoreceptors. Photoreceptors outer segments (OS), inner 
segments (IN), and synaptic terminals (ST).
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(nucleus, endoplasmic reticulum, Golgi complex, ribosomes, mitochondria); and the synaptic 
terminal that connects with bipolar neurons of the retina. In vertebrates, the retina is inverted 
in the sense that light passes through secondary and tertiary neuronal layers in the inner retina 
before reaching the rods and cones in the outer retina (Figure 1). Photoreceptors are metaboli-
cally very active cells that require large amounts of nutrients and generate massive amounts 
of waste. Provision of nutrients and removal of waste are critical support tasks performed by 
the retinal pigment epithelium (RPE), a monolayer of cuboidal cells tightly opposed to the 
photoreceptors through a narrow subretinal space. The multifunctional RPE cells constitute 
the blood-outer retina barrier that controls the movement of nutrients, ions, water, gases, 
and wastes between the photoreceptors and underlying choroidal blood vessels [1], absorbs 
excess light through their melanin granules, performs segments of the visual cycle that regen-
erates the visual pigment, performs daily phagocytosis of photoreceptor outer segments, and 
produces trophic factors necessary for photoreceptor survival [2]. It may be rationalized that a 
fundamental objective of the inverted retina design is to bring photoreceptors in close contact 
with RPE, a key relationship for the integrity of the retina.
1.2. Role of RPE in visual-pigment regeneration
In 1967, George Wald was awarded the Nobel Prize for revealing the essential role of Vitamin 
A for vision [3]. Vitamin A entirely is derived from the diet. A critical function of RPE cells is 
to supply the vitamin A-derived chromophore, 11-cis retinal, required for the light-sensing 
function of visual pigments to photoreceptor cells. Visual pigments are G-protein receptors 
(opsins) covalently linked to 11-cis-retinal. Opsins cannot respond to light by themselves but 
need their prosthetic group, 11-cis-retinal that undergoes cis-trans isomerization upon illu-
mination. The absorption characteristics of 11-cis retinals, in different pigments, are deter-
mined by the opsins. Humans have four types of visual pigments: rhodopsin, expressed by rod 
photoreceptors, which is sensitive to dim light and provides black-and-white vision; L-opsin, 
M-opsin, and S-opsin expressed by cone photoreceptors sensitive to red, green, and blue color 
lights, respectively [4]. When light strikes the visual pigments, it promotes isomerization of 
11-cis retinal into all-trans retinal (ATR), which in turn promotes the structural rearrangement 
of opsin into an active conformation that initiates phototransduction (Figure 2).
To recover photosensitivity, opsin must be regenerated by releasing all-trans retinal and bind-
ing new 11-cis retinal. Released all-trans retinal is pumped out of the disks into the cytosol by 
a photoreceptor specific ATP-binding transporter (ABCA4) and reduced to all-trans-retinol 
by all-trans-retinal dehydrogenases (RDH8 and RDH12). All-trans-retinol diffuses into the 
RPE where it is esterified by lecithin:retinol acyltransferase (LRAT) to all-trans-retinyl esters, 
which are stored in retinosomes. All-trans-retinyl esters are isomerized by 65-kDa RPE-
specific  protein (RPE65) to 11-cis retinol, which is oxidized to 11-cis retinal before traveling 
back to the photoreceptors outer segment where it is again conjugated to an opsin to form 
new, functional visual pigment. These series of metabolic steps, by which all-trans-retinal 
is converted to regenerate the visual pigments, constitute the classical visual cycle [5]. As 
described above, the RPE performs a number of critical steps in the classical visual cycle that 
provides 11-cis retinal to rods and cones. There is also a cone-specific visual cycle [6], which 
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is RPE independent, that will not be discussed here. The RPE can also generate 11-cis retinal 
from vitamin A captured via its transmembrane transporter Stra6 from the choroidal circu-
lation. Another important source of 11-cis retinal is the retinosomes, i.e., intracellular lipid 
droplet deposits of all-trans-retinyl esters in the cytoplasm of RPE cells (Figure 2).
1.3. Lipid-bisretinoid (LB) biogenesis
Vitamin A aldehydes (retinaldehydes) are highly reactive molecules capable of forming 
adducts with biological amines without the need for a catalyst [7]. In the disks of photore-
ceptor outer segments (POSs), retinaldehyde concentrations are relatively high, due to the 
all-trans-retinal released by photo-transduction and the 11-cis-retinal conveyed for the regener-
ation of visual pigments (Figure 2). Not surprisingly, POS' retinaldehydes tend to covalently 
react with the amine group of phosphatidyl-ethanolamine (PE) to form N-retinylidene-PE 
(NRPE), which reacts with the second molecule of retinal to produce lipid-bisretinoids (LBs). 
Thus, LBs are a family of adducts, all structurally related, that derive from the condensation 
of two retinaldehydes with one PE molecule [8, 9].
Figure 2. Classical visual cycle. Light induces cis-trans isomerization of retinal in visual pigments. All-trans retinal is 
released from opsins and pumped to the cytosol by ABCA4 where is reduced to all-trans-retinol by dehydrogenases 
(RDH8). All-trans-retinol diffuses into RPE via a series of Interphotoreceptor (IRBP) and cellular (CRBP and CRALBP) 
retinoid-binding proteins. In RPE all-trans-retinol is esterified by lecithin:retinol acyltransferase (LRAT) and is sored as 
retinyl esterin lipid droplets called retinosomes. When mobilized, all-trans-retinyl esters are isomerized to 11-cis-retinol 
by RPE65 and oxidized to 11-cis retinal by RDH5 before traveling back to the photoreceptor disks where it is again 
conjugated to an opsin to form new, functional visual pigment. Circulating retinol-binding protein 4 (RBP4) and its 
membrane receptor STRA6 coordinate 11-cis-retinol uptake into cells with high demand of Vitamin-A.
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1.4. Photoreceptor renewal
Because of their task in vision and proximity to the fast flowing choroidal capillaries, photo-
receptors are continually exposed to high doses of radiant energy and oxygen, which makes 
them prone to photo-oxidative damage. To secure long (decades) of useful life, under these 
demanding conditions, photoreceptors undergo a daily renewal process wherein the most 
distal tips of their POS, comprising the ~100 oldest disks, are removed and equivalent number 
are basally produced to maintain constant outer segment length [10]. This cellular renewal 
process has a circadian rhythm. The rods shed POS most vigorously in the morning, whereas 
cones shed more vigorously at the onset of darkness [11]. The enormous amount of waste 
daily generated by this process is cleared by the adjacent RPE cells. In the mammalian eye, 
one RPE cell serves approximately 40 photoreceptor cells, each of which sheds ~7% of its 
mass per day. RPE engulfs and degrades POS fragments via a receptor-mediated phagocytic 
process similar to that involved in macrophage-mediated removal of apoptotic cells [12, 13]. 
This is an impressive metabolic task for RPE, since each cell must ingest and digest ~4000 
disks before the next phagocytic load. Thus, RPE is one of the most active phagocytic cells in 
the body. Because RPE cells do not divide, they must completely dispose this daily material 
to avoid POS components buildup in their lysosomes.
1.5. RPE lipofuscin accumulation
“Lipofuscin” is the generic name given to subcellular material that accumulates with age 
within the lysosomal compartment of a variety of postmitotic cells and is characterized by 
its golden-orange autofluorescent emission. Very few compounds of animal origin exhibit 
fluorescent emissions in the lipofuscin's region of the spectrum [14]. A fairly rigid structure 
with highly conjugated double bond system is necessary for such fluorescence because, accu-
mulation of lipofuscin is considered an universal biomarker of aging, as it is also referred to as 
“age pigment”. Lipofuscins are resistant to degradation by lysosomes, proteasomes, and are 
not evidently exocytosed. Hence, their accumulation appears irreversible in cells that do not 
divide. Most lipofuscins stain positive for proteins, lipids, and carbohydrates [15]. Their exact 
composition varies among tissues but most commonly contains a large proportion of incom-
pletely degraded proteins [16]. The RPE is one of the tissues with the largest buildups of lipo-
fuscin. RPE lipofuscin increases with age in all healthy eyes [17, 18]. It localizes in lysosomal 
bodies of the RPE [19] and can occupy ~ 20% of the cytoplasmic space by 80 years of age [20].
In order to illuminate the cellular processes responsible for the formation of RPE lipofuscin, 
several groups attempted to analyze RPE-lipofuscin's chemical composition. Eldred and Katz 
[21] were the first to isolate the fluorescent pigments of the RPE lipofuscin. Spectroscopy 
and mass spectroscopy analyses of lyophilized chloroform extracts of RPE cells from healthy 
donors of different ages revealed that the most common fluorophore was a lipid-bisretinoid 
[22], N-retinylidene-N-retinylethanolamine also called A2E [23]. Protocols for in vitro syn-
thesis of A2E as well as its incorporation into lysosomes of cultured RPE were developed, 
allowing to model RPE lipofuscin accumulation in vitro [24, 25]. Further efforts to isolate and 
characterize the remaining chromophores in the chloroform extracts from RPE lipofuscin 
granules, yielded additional LBs, including A2-GPE (A2-glycero-phospho-ethanolamine), 
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A2-DHP-PE (A2-dihydropyridine-phosphatidyl-ethanolamine), all-trans-retinal dimer 
(ATRD), and all-trans-retinal dimer phosphatidyl-ethanolamine (ATRD-PE) (Figure 3) as well 
as several higher molecular weight hydrophobic polymers derived from the reaction between 
A2E and its oxidation products [26–29].
Of note, the chloroform-insoluble fraction of the RPE lipofuscin, which represents 70% of its 
dry weight, was not analyzed in these studies. Thus, to fully characterize this fraction, Schutt 
et al. performed a proteome analysis of sucrose-purified RPE granules [30]. They identified 65 
abundant cellular proteins, which included structural, metabolic, mitochondrial, chaperone, 
transmembrane, and signaling transduction proteins. Many of these proteins were modified 
by reactive carbonyl compounds (4-hydroxynonenol and malonyldialdehyde) and exhibited 
advanced glycation end products (AGEs) [31]. A second study by Warburton et al. [32] identi-
fied 41 proteins, most of which included phagosomal, lysosomal, and photoreceptor proteins 
(including rhodopsin) in agreement with the notion that RPE lipofuscin was mainly a buildup 
of undigested POS material. Surprisingly, only 12 proteins (11%) of Warburton's list were 
common with the 65 proteins identified by Schutt et al. This discrepancy probably results 
from variations in the purity of sucrose-isolated granules [33] and from the fact that lipofus-
cin proteins are microheterogeneous in size due to abundant oxidative modifications while 
contaminant proteins are intact and therefore, run as well-focused spots. In a third study, 
Ng et al. [34] analyzed the composition of highly purified RPE-lipofuscin granules devoid of 
Figure 3. LBs found in RPE lipofuscin. R1, R2 are fatty acids with 14 to 22 carbons and 0 to 6 double bonds.
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membranes and reported that the luminal material was 98% lipids, mostly LBs [35]. Taking all 
this information into account, the current concept is that RPE lipofuscin originates from LBs 
in photoreceptors and is transferred to RPE lysosomes during POS phagocytosis. This model 
is supported by animal studies that show that accumulation of lipofuscin in the RPE only 
occurs if (i) there is a supply of 11-cis-retinal to synthesize visual pigments, as RPE65−/− mice 
display no lipofuscin [36] and (ii) there is phagocytosis of POS, since no accumulation of lipo-
fuscin is detectable in phagocytosis-defective animals. In healthy individuals, LB formation 
occurs slowly because the concentrations of retinaldehydes are relatively low, thereby, taking 
many years to generate significant amounts of LBs. In contrast, in individuals with mutations 
in ABCA4, the formation of LBs is dramatically accelerated [37].
1.6. Cellular toxicity caused by RPE lipofuscin accumulation
In retinal diseases associated with the accumulation of LBs in RPE lysosomes, vision loss is 
the result of the death of photoreceptor cells secondary to the functional impairment of RPE. 
Cell culture experiments have shown that lysosomal accumulation of LBs can cause RPE cell 
death [38]. However, how exactly lipofuscin accumulation disrupts RPE performance and 
viability is not fully understood. The variety of LB-elicited toxic mechanisms proposed so far 
(Figure 4) and their investigation as potential pharmacological targets are discussed below.
1.6.1. Phototoxicity
In vitro data with both, whole lipofuscin granules [39] or individual bisretinoids (A2E [40], 
all-trans-retinal dimer [27] and A2-GPE [41]) loaded into lysosomes have shown that LBs 
Figure 4. Modeling the effect of LB accumulation on RPE's lysosomal function. LBs cause loss of lysosomal function by 
inhibition of v-ATPase, oxidative damage, and/or LMP leading to buildup of undigested POS, autophagy material and 
TFEB-mediated lysosomal stress. TFEB induced activation helps RPE to transitorily cope with the LB burden.
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sensitize RPE cells to light exposure. Cellular photosensitivity is proportional to the amount 
of LBs accumulated [42] and the wavelength, with a maximum at 430 nm (blue light), which 
coincides with the excitation spectrum of the LBs [43]. The absorption of blue photons by 
the LBs' extended double bond conjugated system, in the presence of oxygen, leads to the 
formation of oxidized LB species [44, 45] that after repetitive oxidative attacks become frag-
mented into far reaching, highly reactive, carbonyl bearing small molecules [43, 44, 46–48]. 
These fragments promote cell damage by forming Schiff base adducts with free amine groups 
in lysosomal hydrolases, nucleotides, phospholipids, lipids, proteins [49], DNA [50], protea-
somes [51], and molecules in extracellular retinal deposits (drusen), which could trigger local 
innate and adaptive immune responses [52, 53]. Interestingly, healthy mice immunized with 
Schiff base adducts found in the AMD lesions, developed AMD-like retinal pathology [54]. 
There is also in vivo evidence indicating that RPE lipofuscin undergoes photodegradation in 
the eye. Ueda et al [55] showed that ABCA4−/− animals were more susceptible to light damage 
than WT animals and that in both groups, older animals carrying larger amounts of LBs were 
also more susceptible. More recently Ref. [56] showed that RPE-lipofuscin photodegradation 
takes place in mouse eyes under standard ambient illumination. Specifically, they found 
that WT and ABCA4−/− mice reared in constant darkness contained 45 and 62% more LBs in 
the RPE than their respective 12-h cyclic light-reared controls. In addition, ABCA4−/− mice 
who received vitamin E, a potent inhibitor of LB oxidation [44], displayed 54% more LBs 
than controls. Studies in humans, using fluorescence microscopy for quantifying lipofuscin, 
and MALDI-IMS (high-resolution matrix assisted laser desorption-ionization imaging mass 
spectrometry) for detecting A2E showed that lipofuscin fluorescence colocalized with A2E 
only in the darkest zones of the retina [57]. When the same technology was applied to the 
eyes of ABCA4−/− mice, lipofuscin fluorescence, and A2E colocalized 100% [58]. Since RPE is 
exposed to higher levels of illumination in eyes from diurnal than nocturnal species, these 
data suggest that A2E is much more photooxidized into MALDI-IMS unidentifiable fluores-
cent derivatives in human eyes than in mice eyes. However, how much LB photooxidation 
contributes to retinal pathology is an open question. There is a large amount of clinical trial 
data on the use of antioxidants (lutein, zeaxanthin, and vitamins C and E) supplementation 
(alone or in combination) to prevent or delay retinal degeneration. A Cochrane meta-analysis 
performed on four large, high-quality–randomized clinical trials involving a total of 65,250 
participants, without signs of AMD at baseline showed no effect of antioxidant therapy for 
preventing the onset of retinal degeneration per se [59]. Another Cochrane review meta-anal-
ysis [60] involving data from 13 randomized clinical trials, including two large trials, the 
AREDS1/2 and the Vitamin E Intervention in Cataract and Age-Related Maculopathy study, 
and 11 smaller (20–400 participants) randomized trials were performed to decide whether 
antioxidants can slow progression of retinal damage in patients with established AMD. The 
AREDS1/2 shows that long-term, high-dose supplementation with vitamin E (400 IU), vita-
min C (500 mg), beta-carotene (15 mg), zinc (80 mg), and copper (2 mg) reduced the risk of 
progression to geographic atrophy AMD by 8% in only a subgroup of patients with interme-
diate AMD at baseline. The other 11 trials demonstrate little evidence for the effectiveness 
of antioxidant therapy for preventing either visual loss or AMD progression. In summary, 
treatments with antioxidants have shown very modest efficacy at preventing or stopping the 
progression of lypofuscin-associated retinal degenerations. Indeed, patients with mutations 
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in ABCA4 (Stargardt-1, CRD, and RP) gene are not cured by high-doses of antioxidants [61]. 
This may indicate that scavenging reactive oxygen species is not the best approach to halt 
LB-driven damage. Alternatively, LB-photooxidation could be damaging through its pro-
pensity to activate the complement system [62]. In support of this idea, there is a histologic 
evidence of complement deposition in drusen of retinas with AMD [63] and animal studies 
show that overexpression of inhibitors of complement protects retinas of mice with elevated 
LB content [64]. Furthermore, genetic polymorphism in genes encoding complement fac-
tor H (CFH), CFB component C2, CFI, and complement components 2, 3 and 7 has been 
associated with elevated risk for LB-driven retina disease. Initially, there was a tremendous 
excitement to test complement inhibitors in the eye. Out of a dozen tested, only 1 molecule, 
Lampalizumab (Genentech), has made it into phase 3 clinical trials. In the phase 2 clini-
cal test, Lampalizumab decreased the rate of growth of the geographic atrophy area, espe-
cially those with CFI polymorphisms [65]. Two world-wide multi-center prospective phase 
3 clinical trials, which are enriched with CFI subjects, are now fully enrolled and results are 
expected in early 2018.
1.6.2. Inactivation of lysosome-dependent degradative processes
Because RPE cells are the most active postmitotic phagocytes in the body, they heavily rely 
on the fitness of their degradative machinery to operate. Indeed, a high baseline of autoph-
agic activity level has been detected in the RPE and photoreceptors [66, 67], which were 
further enhanced during periods of POS phagocytosis [68]. Digestion of rhodopsin is also 
necessary for adaptation of rods to changes in light intensity [69]. Chemical or genetic inhibi-
tion of autophagy in RPE cells increased accumulation of undigested material and reduced 
cell viability [70]. Deletion of the autophagy inducer gene RB1CC1 in rodent RPE caused 
severe retinal degeneration, underlining the importance of basal autophagy [71]. Histological 
examination of retinas from Stargardt and AMD subjects revealed massive accumulation of 
lysosomal material similar to lipofuscin in the apical regions of RPE cells and of extruded 
extracellular deposits (drusen and pseudo-drusen) that support the idea of a defect in the 
recycling of endocytic and autophagic cargoes [72, 73]. In vitro experiments in which exog-
enous A2E was loaded in the lysosomes of cultured RPE cells, as surrogate of lipofuscin accu-
mulation, show also a significant impairment in the digestion of phagocytized POS [74, 75] 
and autophagocytized proteins [76], implying lysosome-dependent degradative pathways 
are a primary point of attack by LB accumulation. The mechanism by which LBs mediate 
these inhibitions is not fully understood yet. Measurements of lysosomal protease, lipidase, 
glycosidase, nucleases, sulfatase, and phosphatase activities in homogenates of RPE revealed 
that A2E does not inhibit lysosomal activity by direct interaction with the hydrolases [77]. 
Lysosomes-containing A2E seems to have increased pH [74]. Bergmann et al. [76], work-
ing with purified lysosomes, provided evidence that A2E inhibits the vacuolar H(+)-ATPase 
(v-ATPase). v-ATPase is a transmembrane lysosomal protein in charge of maintaining the 
acidic environment within the lysosomes. Because acidic conditions are a prerequisite for 
the activity of lysosomal hydrolases, A2E-induced increase of lysosomal pH would explain, 
in part, its effect on lysosomal functions and autophagy [78]. Consistently, restoration of 
acidic pH in RPE lysosomes has shown promising results at improving lysosomal dependent 
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degradative processes [79]. Furthermore, v-ATPase, together with mTORC1 complex, Rag 
GTPases, Ragulator, and Rheb, is an essential component of the lysosome nutrient-sensing 
(LYNUS) complex [80]. Under conditions of plenty of food, the v-ATPase complex senses lumi-
nal amino acids [81] and recruits mTORC1 to the lysosomal surface where it gets activated 
by phosphorylation [82]. Active mTORC1 complex is the main kinase negatively controlling 
autophagy and lysosomal biogenesis. When v-ATPase is inhibited by starvation, mTORC1 is 
released from the lysosome, becomes immediately inactive by dephosphorylation, and can 
no longer inhibit autophagy or TFEB nuclear translocation [83, 84]. The latter, by increasing 
lysosomal number, trafficking, hydrolase content, initiation of autophagy [85, 86], and lipid 
catabolism [87], facilitates the rapid degradation of a variety of substrates. How A2E inhibi-
tion of v-ATPase affects these cascades is not yet understood. Few studies have character-
ized the status of endogenous mTORC1 and TFEB in the RPE [88–90] and no enough data 
are available for LB-loaded RPE. A likely scenario is that TFEB activation by LBs provides a 
first line of defense that is insufficient to address accumulating autophagosomes containing 
partially degraded POS. However, in the absence of such lysosomal stress response, the RPE 
might succumb even faster. This model would explain experimental data showing that A2E 
induced a concentration- and time-dependent protective autophagic response in RPE cell 
cultures. [91]. Clinical trials using rapamycin, a mTORC1 specific inhibitor, to treat advanced 
stages of AMD showed no positive results [92, 93].
1.6.3. Lysosomal membrane permeabilization (LMP)
The A2E molecule contains a central pyridinium ring that houses permanently positive amine 
nitrogen and two long hydrophobic polyene arms. A similar structure is shared by other LBs, 
including A2-GPE, A2PE, and their isomers. Instead, A2-DHP-PE, all-trans-retinal (ATRD), 
all-trans-retinal dimer-E (ATRD-E), and all-trans-retinal dimer-PE (ATRD-PE) have non-
charged ring cores, although ATRD-E and ATRD-PE have protonable nitrogens that confer 
them with amphipathic character at low pH. Amphiphatic LBs have the potential to interca-
late into membranes [22, 94]. Schutt et al [95] investigated the destabilizing effects of A2E on 
purified lysosomes by measuring the release of luminal β-hexosaminidase to the supernatant. 
Concentrations as low as 2 μm induced leakage, whereas plasma membranes were insensitive 
to much higher concentrations. In support of the idea that amphipathic LBs cause lysosomal 
membrane permeabilization (LMP) is the observation that RPE cells loaded with lipofuscin 
granules or A2E into their lysosomes undergo significant LMP [40]. Multiple mechanisms can 
be responsible for A2E mediating LMP. A2E can act as a surfactant and cause direct mem-
brane damage. De and Sakmar [94] found that A2E-induced leakage of liposomes at concen-
trations of 200–300 μm. LMP could also be the result of A2E crystallization within lysosomes, 
which might cause inflammation by activating a multimolecular signaling complex of the 
innate immune system, the NLRP3 inflammasome, resulting in a caspase-1–mediated activa-
tion and secretion of mature IL1β family cytokines [96, 97]. Relevantly, A2E accumulation 
induces NALP3-mediated secretion of mature IL1β [98]. Fluorescence staining of lipofuscin 
revealed a membrane bound autofluorescent granule with the bulk of A2E in the lumen rather 
than in the membrane. Atomic force microscopy shows the core of the granule comprises of 
solid mini aggregates [99]. Accordingly, we observed A2E (MW 592 Da) in aqueous media 
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cannot cross 0.10 micron pore size filters with molecular weight cutoff of 300,000 Da. This 
retention was due to size exclusion as A2E passed through 3 micron filters of the same mate-
rial (Figure 5).
Toxicity of lipofuscin could also involve other less-studied mechanisms, including mito-
chondrial poisoning, as it has been shown that lysosomal A2E progressively leaks into the 
mitochondrial compartment [100], where it destabilizes the membrane [101] and inhibits oxi-
dative phosphorylation [102], derail of cholesterol trafficking [103], activation of Retinoid 
Acid Receptor (RAR)-dependent VEGF secretion in RPE [104, 105], and inhibition of RPE-65 
isomerohydrolase activity, which limits the RPE supply of 11-cis retinal [106]. In summary, 
although numerous mechanisms of toxicity elicited by pathologic accumulation of LBs in RPE 
lysosomes have been proposed, no viable therapeutic options have resulted yet from targeting 
them. Hence, strategies to reduce LB accumulation from RPE have been further investigated.
2. Strategies to reduce lipofuscin accumulation in RPE cells
Alternative strategies to mitigate the cytotoxic effects of LBs involve preventing their accumu-
lation. Two approaches have been pursued (1) to prevent de novo formation of LB and (2) to 
remove previously accumulated LB.
2.1. Strategies that prevent de novo formation of LBs
Long-term restriction of vitamin A intake has been shown to reduce retinaldehyde levels in 
RPE but is not a therapeutic option, since it causes night blindness and systemic hypovita-
minosis [107]. In 2005, Radu et al. [108] showed that oral administration of a synthetic form 
of vitamin A (fenretinide), already in use against cancer, acne, cystic fibrosis, rheumatoid 
arthritis, and psoriasis, could competitively block RBP4 transport of vitamin A from the 
Figure 5. LBs form crystal-like aggregates in aqueous environment. (A) Turbidity of A2E dilutions in water versus 0.1 M 
βCD. (B) Passage through 0.10 micron pore filters (MW cutoff of 300,000 Da) of LBs in water or βCD solutions. (C) 
Autofluorescent detection of A2E (MW 592 Da) and ATRD (600 Da) in pre and post filtrates. Retention was due to size 
exclusion since they crossed 3 micron filters of identical material (not shown).
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blood to the RPE. Oral fenretinide produced mild reversible skin dryness and night blind-
ness. However, in 2011, a phase-2 study on 225 AMD patients failed to show beneficial effects. 
Oral emixustat hydrochloride is a synthetic nonretinoid reversible inhibitor of the RPE65 
enzyme, which converts all-trans-retinyl to 11-cis-retinal, a rate-limiting reaction of the visual 
cycle. This drug showed minimal toxicity in phase-1 trials and effectively reduced photo-
receptor response to light, consistent with its mechanism of action. However, in May 2016, 
the results from the phase 2b/3 SEATTLE study did not show any significant difference in 
retinal degenerative rate or visual acuity changes. Oral deuterated vitamin A (ALK-001), is 
vitamin A modified by replacing hydrogen with deuterium, a safe, nonradioactive isotope. 
Deuterated vitamin A has lower tendency to spontaneously dimerize into LBs. Long-term, 
oral administration of ALK-001 to ABCA4−/− reduced the accumulation of lipofuscin and 
A2E by 70 and 80%, respectively [109]. Assessment of the retina electric response to light 
signals (electroretinogram) revealed that ALK-001 treatment prevented the gradual loss of 
visual function observed in the ABCA4−/− mouse. Safety phase-1 clinical trials have been com-
pleted but phase-2 is ongoing. It is too early to know whether ALK-001 will be beneficial for 
Stargardt or AMD patients.
Oral aldehyde traps (VM200, Vision Medicines) constitute of new drugs that react with reti-
naldehydes forming reversible Schiff bases and thus, reducing the available levels of free 
aldehydes with cellular amine groups. In preclinical studies, VM200 preserved retinal struc-
ture and function of mice retinas in a dose-dependent manner [7]. Safety phase-1 is in prog-
ress but there is no effectiveness data in humans.
In summary, none of the visual cycle modulators have made it out of the nearly half a dozen 
phase 1 and phase 2 clinical trials, so far. They all cause significant night blindness that limit 
their use. Although they all seem very effective at slowing down the formation of new LBs in 
animals, they lack effect on previously accumulated LB, which may explain why fenretinide 
or emixustat did not benefit patients already diagnosed with AMD. Likewise in animal mod-
els, where these drugs are given preventively for long periods, humans may need to take 
them early, i.e., much before the clinical manifestations appear, and for life.
2.2. Strategies for removing previously accumulated LB
Potentially, their main advantage over agents that prevent accumulation of LBs is that they 
might be administered to patients with Stargardt or AMD who display large buildup of LBs. 
Most of these strategies are in preclinical stage.
2.2.1. Oral soraprazan (Katairo GmbH)
In 2012, Schraermeyer's group reported successful elimination of lipofuscin from RPE cells 
in monkey retinas after 1 year of oral administration of the drug. Researchers showed that 
lipofuscin granules were expelled by RPE cells toward their basolateral side and were cleared 
by macrophages recruited to the area [110]. Although soraprazan is known to reversibly block 
the potassium binding site of the gastric H+/K+ ATPase proton pump, the precise mechanism 
by which it causes clearance of LB deposits is unknown.
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2.2.2. Enzymatic degradation of LBs
Because LBs are refractory to degradation by lysosomal hydrolases, several groups searched 
for exogenous enzymes with LB destroying activity. Horseradish peroxidase (HRP) was the 
first one identified [111]. It catalyzes the oxidative cleavage of the polyene–arms of LBs. To 
test the effectiveness of HRP, cultures of RPE cells preloaded with LBs underwent an enzyme 
replacement therapy-like treatment with HRP. The efficiency of the clearance was low but 
the major problem was the considerable amount of highly toxic reactive molecules released 
as a by-product of the HRP-mediated oxidation of LBs [112]. It was more recently reported in 
Ref. [113] that neutrophil myeloperoxidase (MPO) catalyzes the in vitro degradation of A2E. 
The authors delivered MPO to lysosomes of RPE cells via mannose-6-phosphate (M6P) recep-
tor. M6P-MOP exhibited a half-life of 10 h in the lysosomes and degraded lysosomal A2E in, 
but also disrupted lysosomal acidification and triggered lysosomal stress, manifested by the 
nuclear translocation of TFEB that eventually led to cell death. Thus, the strategy of eliminat-
ing LBs with peroxidases seems to be limited by the inherent associated release of detrimental 
reactive species, which would be equivalent to try to clear LBs by photooxidation.
2.2.3. Beta-cyclodextrins (β-CDs)
βCDs are membrane-impermeant cyclic sugars made of seven glucose residues. They contain 
a nonpolar central cavity that is capable of accommodating hydrophobic ligands and a hydro-
philic outer surface that makes them soluble in water [114]. Several FDA-approved cyclo-
dextrins are currently used to improve the delivery of lipophilic drugs. We demonstrated 
that βCDs form soluble complexes with LBs [115] (Figure 5). In silico modeling predicted 
2:1 βCD-A2E complex, where one βCD accommodates per arm of LB. We also observed that 
βCDs reduced the content of A2E from polarized RPE monolayers on Transwell filter cultures 
and from RPE in the eyes of mice that accumulate massive amounts of lysosomal LBs [116] 
indicating that βCD treatment can eliminate not only A2E, but also the complex LB mixes 
found in RPE lipofuscin. The mechanisms by which βCDs induce clearance of lysosomes' 
content in RPE is yet to be determined but could potentially be optimized to develop a novel 
therapeutic approach to clear LB-buildups. The mechanism of cholesterol removal by βCDs 
is one of the best characterized. Likewise LBs, cholesterol forms soluble inclusion complexes 
with βCDs. In normal cells, cholesterol is more abundantly present in plasma membrane, 
common recycling endosome and trans-Golgi complex [117]. Removal of cholesterol from 
these membranes, requires high concentrations (5–10 mM) and prolonged times because 
βCDs, which have an ~8 Ǻ deep cavity, must form stacked dimers (improbable event) to 
remove 18 Ǻ long cholesterols out of the lipid bilayer and shelter them from the water [118]. 
In cells with Niemann Pick Type-C defect, i.e., with inactivating mutations in either NPC1 
or NPC2 genes, that code for two intra-lysosomal lipid transporter proteins, cholesterol is, 
also, aberrantly accumulated within lysosomes. Removal of lysosomal cholesterol buildups 
requires lower concentrations (0.1–1.0 mM) and shorter incubation times with βCD [119]. 
Furthermore, sulfo-butyl-ether-βCD (Captisol®), a βCD derivative that cannot form stacked 
dimers and that therefore cannot solubilize membrane cholesterol, can still reduce lysosomal 
buildups [120]. The model for βCD-mediated removal of lysosomal cholesterol proposes that 
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βCD enters lysosomes by endocytosis, where it binds free cholesterol in the lumen and shuttle 
it to the limiting lysosomal membrane [121, 122]. From there, cholesterol is transferred, by 
a not fully characterized trafficking machinery, that probably involves points of membrane 
contact between organelles and cholesterol binding proteins [123], to the ER, plasma mem-
brane, peroxisomes, and mitochondria [124, 125]. In the absence of extracellular cholesterol 
acceptor molecules, the stoichiometric analysis of βCD clearance provides no evidence of 
cholesterol release to the media but rather indicates a rapid metabolic processing within the 
cytosolic compartment [126, 127]. In the case of LBs, if βCDs clearance works similarly, then 
it would be important to see what putative LB-transport system acts thereafter to ship LBs for 
degradation [85, 128] or to expel them from the cell. Confirmation of such operating traffick-
ing pathway could represent an important advance to identify pharmacological targets for the 
elimination of lysosomal LBs.
In a mice model of atherosclerosis [129], βCDs have shown effective removal of cholesterol 
crystals from macrophage foam cells. The mechanism in this case seems to be mostly medi-
ated by the execution of a LXR (liver-X-receptor) dependent transcriptional program response 
that enhanced the efflux and degradation of cholesterol and reduced inflammation.
Administration of βCD also lowered the levels of amyloid-β in an animal model of Alzheimer 
Disease [130] and from drusen deposits in animal models of Stargardt disease [131]. The mech-
anism in these cases is less clear but it seems to be transcriptionally controlled. Accordingly, 
it will be important to determine if βCDs trigger a transcriptional program that primes RPE 
cells to eliminate its lysosomal content, independently on whether they form soluble com-
plex with the wasted material. Similarly, fibroblasts from patients with ceroid-lipofuscinosis, 
the most common cause of neurodegeneration of children in the United States, and cellu-
lar or animal models with misfolded α-synuclein accumulation were cleared by βCDs [132, 
133]. The mechanism in these cases seemed to be mediated by TFEB [86, 134]. The pathway 
responsible for βCD activation of TFEB is not defined and is induced by millimolar doses of 
cyclodextrins. βCDs appear to induce autophagy [135] and exocytosis of lysosomes [136]. 
Finally, overexpression of activated TFEB has been demonstrated to ameliorate pathology in 
late-onset neurodegenerative diseases such as Parkinson, Huntington and Alzheimer, as well 
as in models of spinal and bulbar muscular atrophy and to clear deposits in lysosomal storage 
disorders (LSDs) [83, 86, 137–139]. Thus, it will be important to determine whether TFEB is 
necessary or if it can synergistically contribute to the clearance of RPE lipofuscin.
3. Conclusions
Buildup of lipofuscin in RPE lysosomes often evolves into irreversible damage of overlying 
photoreceptors. This is a common event in individuals with mutations in ABCA4 gene and is 
believed to underlie the progression of age-related lesions in AMD people, the most common 
cause of blindness in the elderly population. Unfortunately, the great majority of patients 
diagnosed with this problem have no therapeutic options available. Analysis of RPE lipofus-
cin, identified as major components lipid bisretinoids (LBs), sub-products of the spontaneous 
dimerization of retinaldehydes produced during the visual cycle. Targeting LBs secondary 
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complications with oral antioxidants, inhibitors of complement or autophagy inducers pro-
vided no or little beneficial effect. The recent failures in clinical trials with visual cycle modu-
lators, which prevent de novo formation of LBs may reflect the incapacity of these drugs to 
stop degeneration once LB-accumulation has been established, which is probably the case 
for most individuals with clinical symptoms. Hence, the development of novel strategies 
to permanently remove previously accumulated lipofuscin is an urgent medical need. The 
characterization of LBs as the core-components of RPE lipofuscin has permitted to rationally 
develop strategies to remove them from RPE cells in the laboratory. This, combined with an 
improved understanding of the molecular pathways that govern autophagy and stimulate 
cellular clearance might allow in the near future, to develop improved therapies for retinal 
degenerations resulting from genetic or age-related retinal lipofuscin accumulation.
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